CD8A and gastric cancer: CD8+CD103+TRMs have stronger anti-tumor activity, but exhibit reduced infiltration in gastric cancer, and their cytolytic capacity can be restored by PD-1 blockade and 4-1BB co-stimulation in vitro (88).